Duskin-Bitan Hadar, Cohen Eytan, Goldberg Elad, Shochat Tzippy, Levi Amos, Garty Moshe, Krause Ilan
Department of Internal Medicine F - Recanati, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.
Clin Rheumatol. 2014 Apr;33(4):549-53. doi: 10.1007/s10067-014-2520-7. Epub 2014 Feb 13.
This study was conducted to examine the relationship between the degree of asymptomatic hyperuricemia and the development of gout, in men and women. The database of a screening center was searched for all subjects with asymptomatic hyperuricemia (>7.0 mg/dl men, >5.6 mg/dl women) during 2000-2012. We included men and women without previous diagnosis of gout, and a follow-up of at least 5 years. The risk of gout was analyzed in relation to the degree of hyperuricemia at the first visit. Of the 5,234 subjects who matched the inclusion criteria, 4,241 were normouricemic at their first visit and 993 were hyperuricemic. The mean follow up period was 7.5 years. Gout was diagnosed at the last visit in 34 subjects; four in the normouricemia group and 30 in the hyperuricemia group (0.1 % vs. 3.0 %, p < 0.001). Only one woman developed gout. The odds ratio (OR) for developing gout was 32 times higher in the hyperuricemic group than in the normouricemic group. The OR to develop gout was 11.2 (confidence interval [CI] 3.6-35.2) in men with mild hyperuricemia compared to 107.1 (CI 34.2-334.9) in men with moderate hyperuricemia, and 624.8 (CI 134.0-2,913.1) in men with severe hyperuricemia. Multivariate analysis of uric acid levels, thiazide use, regular alcohol consumption and estimated glomerular filtration rate (eGFR) showed that only the level of uric acid retained statistically significant for increasing the risk of gout. There is a strong association between the absolute level of uric acid and the risk to develop gout, strikingly so for men with severe hyperuricemia. Monitoring is recommended for that group, which poses the greatest risk to develop gout.
本研究旨在探讨男性和女性无症状高尿酸血症程度与痛风发病之间的关系。在一个筛查中心的数据库中,搜索了2000年至2012年期间所有无症状高尿酸血症患者(男性>7.0mg/dl,女性>5.6mg/dl)。我们纳入了既往未诊断为痛风的男性和女性,并进行了至少5年的随访。分析了首次就诊时高尿酸血症程度与痛风风险的关系。在符合纳入标准的5234名受试者中,4241人首次就诊时尿酸正常,993人高尿酸。平均随访期为7.5年。在最后一次就诊时,34名受试者被诊断为痛风;尿酸正常组4人,高尿酸血症组30人(0.1%对3.0%,p<0.001)。只有一名女性患痛风。高尿酸血症组患痛风的比值比(OR)比尿酸正常组高32倍。轻度高尿酸血症男性患痛风的OR为11.2(置信区间[CI]3.6 - 35.2),中度高尿酸血症男性为107.1(CI 34.2 - 334.9),重度高尿酸血症男性为624.8(CI 134.0 - 2913.1)。对尿酸水平、噻嗪类药物使用、定期饮酒和估计肾小球滤过率(eGFR)进行多变量分析显示,只有尿酸水平对增加痛风风险具有统计学意义。尿酸的绝对水平与患痛风的风险之间存在很强的关联,对于重度高尿酸血症男性尤为明显。建议对该组进行监测,因为他们患痛风的风险最大。